查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1949821

2026年全球可生物分解醫用聚合物市場報告

Biodegradable Medical Polymers Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，可生物分解醫用聚合物市場發展迅速，預計將從2025年的27.8億美元成長到2026年的32.4億美元，複合年成長率達16.7%。過去幾年的成長可歸因於可吸收縫合線使用量的增加、可生物分解植入的早期應用、整形外科和心血管外科手術的擴展、聚合物化學的進步以及人們對可吸收材料的接受度不斷提高。

預計未來幾年，可生物分解醫用聚合物市場將快速成長，到2030年市場規模將達到59.5億美元，複合年成長率（CAGR）為16.4%。預測期內的成長可歸因於微創手術需求的不斷成長、對永續醫用材料日益成長的興趣、藥物-醫療設備混合產品的擴張、再生醫學投資的增加以及精密聚合物工程技術的進步。預測期內的主要趨勢包括：生物可吸收植入材料的使用日益增多、對可控分解聚合物的需求不斷成長、聚合物在藥物輸送系統中的應用日益廣泛、先進生物聚合物加工技術的進步以及對生物相容性和安全性的日益重視。

微創手術需求的不斷成長預計將推動可生物分解醫用聚合物市場的未來擴張。微創手術是一種採用微小切口或非侵入性方式進行手術和介入的醫療技術，與傳統手術方法相比，可減少組織損傷、縮短恢復時間並減輕術後不適。醫療技術的進步促進了精準手術技術的廣泛應用，從而推動了此類手術數量的成長。可生物分解醫用聚合物透過製造可在體內自然溶解的臨時植入、縫線和藥物輸送裝置，為微創手術提供支援。這避免了手術取出，減少了組織損傷，並降低了患者的風險，促進了康復。例如，總部位於美國的專業組織——美國整形外科醫師協會在2023年2月報告稱，微創美容手術的數量將從2022年的2370萬例增加到2023年的2540萬例。這種對微創手術日益成長的需求正在推動可生物分解醫用聚合物市場的成長。

生物分解醫用聚合物市場的主要企業正優先採用先進技術，例如生物聚合物技術，以提升醫療設備和藥物輸送系統的性能、生物相容性和永續性。生物聚合物技術是將天然來源的聚合物應用於科學領域，以製造用於醫療、包裝和工業應用的生物分解、環境永續材料，同時減少對合成塑膠的依賴。例如，總部位於瑞士的上市公司蘇爾壽（Sulzer）於2023年11月宣布推出CAPSUL，這是一項用於連續生產生物分解聚酯聚己內酯（PCL）的創新端到端授權技術。這將使該公司能夠以經濟高效的價格提供高品質的PCL產品。此舉旨在推廣永續和生物分解材料，提高生產效率，並為醫療和工業應用提供高品質的環保聚合物。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球可生物分解醫用聚合物市場：吸引力評分及分析
  • 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 主要原料、資源和供應商清單
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章 全球市場趨勢與策略

  • 關鍵技術和未來趨勢
    • 永續性、氣候技術和循環經濟
    • 生物技術、基因組學和精準醫學
    • 工業4.0和智慧製造
    • 數位化、雲端運算、巨量資料、網路安全
    • 人工智慧（AI）和自主人工智慧
  • 主要趨勢
    • 生物可吸收植入材料的使用日益增多
    • 對可控分解聚合物的需求不斷成長
    • 聚合物在藥物傳遞系統中的廣泛應用
    • 擴展先進生物聚合物加工技術
    • 日益重視生物相容性和安全性

第5章 終端用戶產業市場分析

  • 醫療設備製造商
  • 製藥公司
  • 生技公司
  • 研究與開發實驗室
  • 契約製造組織

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球可生物分解醫用聚合物市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 全球可生物分解醫用聚合物市場規模、對比及成長率分析
  • 全球可生物分解醫用聚合物市場表現：規模與成長，2020-2025年
  • 全球可生物分解醫用聚合物市場預測：規模與成長，2025-2030年，2035年預測

第8章 全球潛在市場總量（TAM）

第9章 市場細分

  • 依產品類型
  • 聚乳酸、聚乙醇酸、聚己內酯、聚羥基烷酯及其他產品
  • 依材料類型
  • 陶瓷基質複合材料（CMC）、氧化物陶瓷、非氧化物陶瓷、先進多孔陶瓷
  • 按產品形式
  • 粉末、磁磚、塗料、纖維、散裝
  • 透過使用
  • 藥物傳輸、植入、縫合線及其他應用
  • 按類型細分：聚乳酸
  • 乳酸衍生的聚合物、乳酸共聚物、3D複合聚乳酸
  • 按類型細分：聚乙醇酸
  • 乙醇酸均聚物，與其他單體的共聚物
  • 按類型細分：聚己內酯
  • 鎖狀聚己內酯、支鏈聚己內酯、交聯聚己內酯
  • 按類型細分：聚羥基烷酯
  • 聚羥基丁酸酯、聚羥基戊酸酯、聚羥基丁酸羥基戊酸酯
  • 按類型細分：其他產品
  • 澱粉基聚合物、纖維素基聚合物、蛋白質基聚合物

第10章 區域與國家分析

  • 全球可生物分解醫用聚合物市場：按地區、業績和預測分類，2020-2025年、2025-2030年預測、2035年預測
  • 全球可生物分解醫用聚合物市場：按國家/地區、性能和預測分類，2020-2025年、2025-2030年預測、2035年預測

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 生物可分解醫用聚合物市場：競爭格局及市場佔有率（2024年）
  • 生物可分解醫用聚合物市場：公司評估矩陣
  • 生物可分解醫用聚合物市場：公司概況
    • Evonik Industries AG
    • Corbion NV
    • dsm-firmenich AG
    • Mitsui Chemicals Inc.
    • Poly Medicure Limited

第37章：其他領先和創新企業

  • KLS Martin SE & Co. KG, BASF SE, NatureWorks LLC, Arkema SA, Eastman Chemical Company, Foster LLC, Becton Dickinson and Company, Toray Industries Inc., Celanese Corporation, Teysa Technologies Ltd, Kaneka Corporation, Arthrex Inc., Ashland Inc., Meril Life Sciences India Private Limited, Reva Medical LLC

第38章 全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

  • 2030年生物可分解醫用聚合物市場：提供新機會的國家
  • 2030年生物可分解醫用聚合物市場：充滿新機會的細分市場
  • 2030年生物可分解醫用聚合物市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第41章附錄

簡介目錄
Product Code: PH6MBMPE01_G26Q1

Biodegradable medical polymers are a category of cutting-edge materials designed to break down into non-toxic byproducts in the body or environment once their medical function is fulfilled. They minimize postoperative issues, promote the body's natural recovery, and remove the necessity for surgical removal. With superior biocompatibility and precise degradation control, they play a vital role in progressing contemporary medical therapies.

The primary product types of biodegradable medical polymers include polylactic acid, polyglycolic acid, polycaprolactone, polyhydroxyalkanoates, and others. Polylactic acid is a biodegradable thermoplastic sourced from renewable materials like corn starch and sugarcane, commonly applied in medical and packaging uses. The different material types encompass ceramic matrix composites (CMC), oxide ceramics, non-oxide ceramics, and advanced porous ceramics. The various product forms consist of powder, tiles, coatings, fibres, and bulk. These serve applications such as drug delivery, implants, sutures, and others.

Tariffs are influencing the biodegradable medical polymers market by increasing costs of imported raw materials, specialty monomers, processing equipment, and quality testing instruments used in polymer synthesis and fabrication. Medical device and pharmaceutical manufacturers in North America and Europe are most affected due to dependence on imported high-purity materials, while Asia-Pacific faces pricing pressure on export-oriented polymer production. These tariffs are raising production costs and impacting pricing strategies. However, they are also encouraging regional sourcing of bio-based feedstocks, domestic polymer manufacturing, and innovation in cost-efficient biodegradable material formulations.

The biodegradable medical polymers market research report is one of a series of new reports from The Business Research Company that provides biodegradable medical polymers market statistics, including biodegradable medical polymers industry global market size, regional shares, competitors with a biodegradable medical polymers market share, detailed biodegradable medical polymers market segments, market trends and opportunities, and any further data you may need to thrive in the biodegradable medical polymers industry. This biodegradable medical polymers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The biodegradable medical polymers market size has grown rapidly in recent years. It will grow from $2.78 billion in 2025 to $3.24 billion in 2026 at a compound annual growth rate (CAGR) of 16.7%. The growth in the historic period can be attributed to rising use of absorbable sutures, early adoption of biodegradable implants, expansion of orthopedic and cardiovascular procedures, advancements in polymer chemistry, increasing acceptance of resorbable materials.

The biodegradable medical polymers market size is expected to see rapid growth in the next few years. It will grow to $5.95 billion in 2030 at a compound annual growth rate (CAGR) of 16.4%. The growth in the forecast period can be attributed to increasing demand for minimally invasive procedures, rising focus on sustainable medical materials, expansion of drug-device combination products, growing investments in regenerative medicine, advancements in precision polymer engineering. Major trends in the forecast period include increasing use of bioabsorbable implant materials, rising demand for controlled degradation polymers, growing adoption of polymers in drug delivery systems, expansion of advanced biopolymer processing techniques, enhanced focus on biocompatibility and safety.

The rising demand for minimally invasive procedures is anticipated to fuel the expansion of the biodegradable medical polymers market in the future. Minimally invasive procedures involve medical techniques that employ small incisions or non-invasive approaches for surgeries or interventions, leading to less tissue damage, quicker recovery periods, and reduced postoperative discomfort relative to conventional surgical approaches. These procedures are on the rise thanks to progress in medical technology, which boosts the global uptake of precise surgical methods. Biodegradable medical polymers aid minimally invasive surgeries by facilitating temporary implants, sutures, and drug delivery devices that dissolve naturally in the body, eliminating the need for follow-up removal surgeries, lowering tissue injury, and accelerating patient healing with reduced risks. For example, in February 2023, the American Society of Plastic Surgeons-a US-based professional group-reported that cosmetic minimally invasive procedures grew from 23.7 million in 2022 to 25.4 million in 2023. Thus, the growing demand for minimally invasive procedures is propelling the biodegradable medical polymers market forward.

Major companies in the biodegradable medical polymers market are prioritizing cutting-edge technologies like biopolymer technology to boost the performance, biocompatibility, and sustainability of medical devices and drug delivery systems. Biopolymer technology involves the science and use of polymers from natural origins, crafted to biodegrade and support environmental health, and it produces sustainable materials for medical, packaging, and industrial uses while cutting dependence on synthetic plastics. For example, in November 2023, Sulzer Ltd., a Swiss public company based in Switzerland, unveiled CAPSUL, an innovative end-to-end licensed technology for continuously manufacturing polycaprolactone (PCL), a biodegradable polyester, which allows for high-quality PCL grades at cost-effective prices. This introduction seeks to advance sustainable and biodegradable materials, enhance production efficiency, and deliver premium eco-friendly polymers for medical and industrial purposes.

In July 2023, Evonik Industries AG, a Germany-based chemicals firm, purchased Novachem Corporation for an undisclosed sum. This acquisition allows Evonik to bolster its portfolio of sustainable cosmetic active ingredients by incorporating Novachem's innovative, biotech-derived, and eco-certified actives, while bolstering its System Solutions in the personal care sector across the Americas and advancing its shift toward sustainable specialties. Novachem Corporation, a Canada-based petrochemical firm, produces biodegradable medical polymers.

Major companies operating in the biodegradable medical polymers market are Evonik Industries AG, Corbion N.V., dsm-firmenich AG, Mitsui Chemicals Inc., Poly Medicure Limited, KLS Martin SE & Co. KG, BASF SE, NatureWorks LLC, Arkema SA, Eastman Chemical Company, Foster LLC, Becton Dickinson and Company, Toray Industries Inc., Celanese Corporation, Teysa Technologies Ltd, Kaneka Corporation, Arthrex Inc., Ashland Inc., Meril Life Sciences India Private Limited, Reva Medical LLC

North America was the largest region in the biodegradable medical polymers market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biodegradable medical polymers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the biodegradable medical polymers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The biodegradable medical polymers market consists of sales of sutures, drug delivery systems, wound dressings, orthopedic devices, dental implants, tissue engineering scaffolds, and surgical instruments. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Biodegradable Medical Polymers Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses biodegradable medical polymers market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for biodegradable medical polymers ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The biodegradable medical polymers market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product Type: Polylactic Acid; Polyglycolic Acid; Polycaprolactone; Polyhydroxyalkanoates; Other Products
  • 2) By Material Type: Ceramic Matrix Composites (CMC); Oxide Ceramics; Non-Oxide Ceramics; Advanced Porous Ceramics
  • 3) By Product Form: Powder; Tiles; Coatings; Fibers; Bulk
  • 4) By Application: Drug Delivery; Implants; Sutures; Other Applications
  • Subsegments:
  • 1) By Polylactic Acid: Lactic Acid Derived Polymers; Copolymers Of Lactic Acid; Stereocomplex Polylactic Acid
  • 2) By Polyglycolic Acid: Homopolymers Of Glycolic Acid; Copolymers With Other Monomers
  • 3) By Polycaprolactone: Linear Polycaprolactone; Branched Polycaprolactone; Crosslinked Polycaprolactone
  • 4) By Polyhydroxyalkanoate: Polyhydroxybutyrate; Polyhydroxyvalerate; Polyhydroxybutyrate Hydroxyvalerate
  • 5) By Other Products: Starch Based Polymers; Cellulose Based Polymers; Protein Based Polymers
  • Companies Mentioned: Evonik Industries AG; Corbion N.V.; dsm-firmenich AG; Mitsui Chemicals Inc.; Poly Medicure Limited; KLS Martin SE & Co. KG; BASF SE; NatureWorks LLC; Arkema SA; Eastman Chemical Company; Foster LLC; Becton Dickinson and Company; Toray Industries Inc.; Celanese Corporation; Teysa Technologies Ltd; Kaneka Corporation; Arthrex Inc.; Ashland Inc.; Meril Life Sciences India Private Limited; Reva Medical LLC
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Biodegradable Medical Polymers Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Biodegradable Medical Polymers Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Biodegradable Medical Polymers Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Biodegradable Medical Polymers Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Sustainability, Climate Tech & Circular Economy
    • 4.1.2 Biotechnology, Genomics & Precision Medicine
    • 4.1.3 Industry 4.0 & Intelligent Manufacturing
    • 4.1.4 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.5 Artificial Intelligence & Autonomous Intelligence
  • 4.2. Major Trends
    • 4.2.1 Increasing Use Of Bioabsorbable Implant Materials
    • 4.2.2 Rising Demand For Controlled Degradation Polymers
    • 4.2.3 Growing Adoption Of Polymers In Drug Delivery Systems
    • 4.2.4 Expansion Of Advanced Biopolymer Processing Techniques
    • 4.2.5 Enhanced Focus On Biocompatibility And Safety

5. Biodegradable Medical Polymers Market Analysis Of End Use Industries

  • 5.1 Medical Device Manufacturers
  • 5.2 Pharmaceutical Companies
  • 5.3 Biotechnology Companies
  • 5.4 Research And Development Laboratories
  • 5.5 Contract Manufacturing Organizations

6. Biodegradable Medical Polymers Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Biodegradable Medical Polymers Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Biodegradable Medical Polymers PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Biodegradable Medical Polymers Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Biodegradable Medical Polymers Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Biodegradable Medical Polymers Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Biodegradable Medical Polymers Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Biodegradable Medical Polymers Market Segmentation

  • 9.1. Global Biodegradable Medical Polymers Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Polylactic Acid, Polyglycolic Acid, Polycaprolactone, Polyhydroxyalkanoates, Other Products
  • 9.2. Global Biodegradable Medical Polymers Market, Segmentation By Material Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Ceramic Matrix Composites (CMC), Oxide Ceramics, Non-Oxide Ceramics, Advanced Porous Ceramics
  • 9.3. Global Biodegradable Medical Polymers Market, Segmentation By Product Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Powder, Tiles, Coatings, Fibers, Bulk
  • 9.4. Global Biodegradable Medical Polymers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Drug Delivery, Implants, Sutures, Other Applications
  • 9.5. Global Biodegradable Medical Polymers Market, Sub-Segmentation Of Polylactic Acid, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Lactic Acid Derived Polymers, Copolymers Of Lactic Acid, Stereocomplex Polylactic Acid
  • 9.6. Global Biodegradable Medical Polymers Market, Sub-Segmentation Of Polyglycolic Acid, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Homopolymers Of Glycolic Acid, Copolymers With Other Monomers
  • 9.7. Global Biodegradable Medical Polymers Market, Sub-Segmentation Of Polycaprolactone, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Linear Polycaprolactone, Branched Polycaprolactone, Crosslinked Polycaprolactone
  • 9.8. Global Biodegradable Medical Polymers Market, Sub-Segmentation Of Polyhydroxyalkanoate, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Polyhydroxybutyrate, Polyhydroxyvalerate, Polyhydroxybutyrate Hydroxyvalerate
  • 9.9. Global Biodegradable Medical Polymers Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Starch Based Polymers, Cellulose Based Polymers, Protein Based Polymers

10. Biodegradable Medical Polymers Market Regional And Country Analysis

  • 10.1. Global Biodegradable Medical Polymers Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Biodegradable Medical Polymers Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Biodegradable Medical Polymers Market

  • 11.1. Asia-Pacific Biodegradable Medical Polymers Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Biodegradable Medical Polymers Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Product Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Biodegradable Medical Polymers Market

  • 12.1. China Biodegradable Medical Polymers Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Biodegradable Medical Polymers Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Product Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Biodegradable Medical Polymers Market

  • 13.1. India Biodegradable Medical Polymers Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Product Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Biodegradable Medical Polymers Market

  • 14.1. Japan Biodegradable Medical Polymers Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Biodegradable Medical Polymers Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Product Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Biodegradable Medical Polymers Market

  • 15.1. Australia Biodegradable Medical Polymers Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Product Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Biodegradable Medical Polymers Market

  • 16.1. Indonesia Biodegradable Medical Polymers Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Product Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Biodegradable Medical Polymers Market

  • 17.1. South Korea Biodegradable Medical Polymers Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Biodegradable Medical Polymers Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Product Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Biodegradable Medical Polymers Market

  • 18.1. Taiwan Biodegradable Medical Polymers Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Biodegradable Medical Polymers Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Product Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Biodegradable Medical Polymers Market

  • 19.1. South East Asia Biodegradable Medical Polymers Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Biodegradable Medical Polymers Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Product Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Biodegradable Medical Polymers Market

  • 20.1. Western Europe Biodegradable Medical Polymers Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Biodegradable Medical Polymers Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Product Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Biodegradable Medical Polymers Market

  • 21.1. UK Biodegradable Medical Polymers Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Product Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Biodegradable Medical Polymers Market

  • 22.1. Germany Biodegradable Medical Polymers Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Product Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Biodegradable Medical Polymers Market

  • 23.1. France Biodegradable Medical Polymers Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Product Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Biodegradable Medical Polymers Market

  • 24.1. Italy Biodegradable Medical Polymers Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Product Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Biodegradable Medical Polymers Market

  • 25.1. Spain Biodegradable Medical Polymers Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Product Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Biodegradable Medical Polymers Market

  • 26.1. Eastern Europe Biodegradable Medical Polymers Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Biodegradable Medical Polymers Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Product Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Biodegradable Medical Polymers Market

  • 27.1. Russia Biodegradable Medical Polymers Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Product Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Biodegradable Medical Polymers Market

  • 28.1. North America Biodegradable Medical Polymers Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Biodegradable Medical Polymers Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Product Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Biodegradable Medical Polymers Market

  • 29.1. USA Biodegradable Medical Polymers Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Biodegradable Medical Polymers Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Product Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Biodegradable Medical Polymers Market

  • 30.1. Canada Biodegradable Medical Polymers Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Biodegradable Medical Polymers Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Product Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Biodegradable Medical Polymers Market

  • 31.1. South America Biodegradable Medical Polymers Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Biodegradable Medical Polymers Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Product Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Biodegradable Medical Polymers Market

  • 32.1. Brazil Biodegradable Medical Polymers Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Product Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Biodegradable Medical Polymers Market

  • 33.1. Middle East Biodegradable Medical Polymers Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Biodegradable Medical Polymers Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Product Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Biodegradable Medical Polymers Market

  • 34.1. Africa Biodegradable Medical Polymers Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Biodegradable Medical Polymers Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Product Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Biodegradable Medical Polymers Market Regulatory and Investment Landscape

36. Biodegradable Medical Polymers Market Competitive Landscape And Company Profiles

  • 36.1. Biodegradable Medical Polymers Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Biodegradable Medical Polymers Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Biodegradable Medical Polymers Market Company Profiles
    • 36.3.1. Evonik Industries AG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Corbion N.V. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. dsm-firmenich AG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Mitsui Chemicals Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Poly Medicure Limited Overview, Products and Services, Strategy and Financial Analysis

37. Biodegradable Medical Polymers Market Other Major And Innovative Companies

  • KLS Martin SE & Co. KG, BASF SE, NatureWorks LLC, Arkema SA, Eastman Chemical Company, Foster LLC, Becton Dickinson and Company, Toray Industries Inc., Celanese Corporation, Teysa Technologies Ltd, Kaneka Corporation, Arthrex Inc., Ashland Inc., Meril Life Sciences India Private Limited, Reva Medical LLC

38. Global Biodegradable Medical Polymers Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Biodegradable Medical Polymers Market

40. Biodegradable Medical Polymers Market High Potential Countries, Segments and Strategies

  • 40.1 Biodegradable Medical Polymers Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Biodegradable Medical Polymers Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Biodegradable Medical Polymers Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer